title: Genome-wide transcriptional analysis of differentially expressed genes in flagellin-pretreated mouse corneal epithelial cells in response to Pseudomonas aeruginosa: involvement of S100A8/A9.
abstract: We previously showed that pre-exposure of the cornea to Toll-like receptor 5 ligand flagellin induces profound mucosal innate protection against infections by modifying gene expression. Taking advantage of easily procurable epithelial cell population, this study is the first report to use genome-wide cDNA microarray approach to document genes associated with flagellin-induced protection against Pseudomonas aeruginosa in corneal epithelial cells (CECs). Infection altered the expression of 675 genes (497 up and 178 down), while flagellin pretreatment followed by infection resulted in a great increase in 890 gene upregulated and 37 genes downregulated. Comparing these two groups showed 209 differentially expressed genes (157 up, 52 down). Notably, among 114 genes categorized as defense related, S100A8/A9 are the two most highly induced genes by flagellin, and their expression in the corneal was confirmed by realtime PCR and immunohistochemistry. Neutralization of S100A8 and, to a less extent, A9, resulted in significantly increased bacterial burden and severe keratitis. Collectively, our study identifies many differentially expressed genes by flagellin in CECs in response to Pseudomonas. These novel gene expression signatures provide new insights and clues into the nature of protective mechanisms established by flagellin and new therapeutic targets for reducing inflammation and for controlling microbial infection.
authors: Department of Ophthalmology, Wayne State University School of Medicine, Detroit, Michigan, USA.
authors: N
authors: N
authors: Gao
authors: G
authors: G
authors: Sang Yoon
authors: X
authors: X
authors: Liu
authors: X
authors: X
authors: Mi
authors: W
authors: W
authors: Chen
authors: T J
authors: TJ
authors: Standiford
authors: F-S X
authors: FS
authors: Yu
mesh_terms: D000818:Animals; D019138:Antibodies, Blocking / Q000008:administration & dosage; D058491:Bacterial Load; D040501:Calgranulin A / Q000235:genetics / Q000378:metabolism*; D040502:Calgranulin B / Q000235:genetics / Q000378:metabolism*; D015169:Colony Count, Microbial; D003315:Cornea / Q000473:pathology; D004847:Epithelial Cells / Q000276:immunology*; D005260:Female; D005408:Flagellin / Q000494:pharmacology; D020869:Gene Expression Profiling; D055106:Genome-Wide Association Study; D007110:Immunity, Active; D051379:Mice; D008810:Mice, Inbred C57BL; D046228:Microarray Analysis; D011552:Pseudomonas Infections / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D051198:Toll-Like Receptor 5 / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D019138:Antibodies, Blocking; D040501:Calgranulin A; D040502:Calgranulin B; D051198:Toll-Like Receptor 5; D005408:Flagellin